PTH-dependence of the effectiveness of cinacalcet in hemodialysis patients with secondary hyperparathyroidism

Cinacalcet lowers parathyroid hormone levels. Whether it can prolong survival of people with chronic kidney disease (CKD) complicated by secondary hyperparathyroidism (SHPT) remains controversial, in part because a recent randomized trial excluded patients with iPTH <300 pg/ml. We examined cinaca...

Descripción completa

Detalles Bibliográficos
Autores principales: Akizawa, Tadao, Kurita, Noriaki, Mizobuchi, Masahide, Fukagawa, Masafumi, Onishi, Yoshihiro, Yamaguchi, Takuhiro, Ellis, Alan R., Fukuma, Shingo, Alan Brookhart, M., Hasegawa, Takeshi, Kurokawa, Kiyoshi, Fukuhara, Shunichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2016
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4829837/
https://www.ncbi.nlm.nih.gov/pubmed/27071541
http://dx.doi.org/10.1038/srep19612

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4829837/
https://www.ncbi.nlm.nih.gov/pubmed/27071541
http://dx.doi.org/10.1038/srep19612

Ejemplares similares